Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic Patients
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Islet autoimmunity has long been recognized in the pathogenesis of type 1 diabetes and is becoming increasingly acknowledged as a component in the pathogenesis of type 2 diabetes. Islet reactive T cells and autoantibodies have been demonstrated in type 1 diabetes, whereas islet autoimmunity in type 2 diabetes has been limited to islet autoantibodies. In this study, we investigated whether islet reactive T cells might also be present in type 2 diabetic patients and how islet reactive T cells correlate with β-cell function. RESEARCH DESIGN AND METHODS: Adult phenotypic type 2 diabetic patients (n = 36) were screened for islet reactive T-cell responses using cellular immunoblotting and five islet autoantibodies (islet cell antibody, GADA, insulin autoantibody, insulinoma-associated protein-2 autoantibody, and zinc transporter autoantibody). RESULTS: We identified four subgroups of adult phenotypic type 2 diabetic patients based on their immunological status (Ab−T−, Ab+T−, Ab−T+, and Ab+T+). The Ab−T+ type 2 diabetic patients demonstrated T-cell responses similar to those of the Ab+T+ type 2 diabetic patients. Data were adjusted for BMI, insulin resistance, and duration of diabetes. Significant differences (P < 0.02) were observed among groups for fasting and glucagon-stimulated C-peptide responses. T-cell responses to islet proteins were also demonstrated to fluctuate less than autoantibody responses. CONCLUSIONS: We have identified a group of adult autoimmune phenotypic type 2 diabetic patients who are Ab−T+ and thus would not be detected using autoantibody testing alone. We conclude that islet autoimmunity may be more prevalent in adult phenotypic type 2 diabetic patients than previously estimated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Staggeringly, islet reactive T-cells were found in 72% of phenotypic T2D patients that participated in one study, which was an unexpected finding, especially as great care was taken to select patients that had minimal chance of being misdiagnosed with T2D and have T1D”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [315]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705894104 · Cited by 1,014
Principles and Practice of Medical Genetics
Pembrey, M. (1984) · Archives of Disease in Childhood · doi:10.1136/adc.59.2.192 · Cited by 776
Yu, L., Robles, D. T., Abiru, N., Kaur, P., Rewers, M., Kelemen, K., & Eisenbarth, G. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040556697 · Cited by 450 · cited 1×
“IAA was measured by a micro-radiobinding assay as previously described (20).”
Islet Inflammation in Type 2 Diabetes
Donath, M. Y., Schumann, D. M., Faulenbach, M., Ellingsgaard, H., Perren, A., & Ehses, J. A. (2008) · Diabetes Care · doi:10.2337/dc08-s243 · Cited by 334 · cited 1×
“diabetes includes the presence of cytokines (2, 3) and the infiltration of immune cells (3,4).”
Principles and Practice of Medical Genetics.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-817_2 · Cited by 290
Greenbaum, C. J., Mandrup-Poulsen, T., McGee, P. F., Battelino, T., Haastert, B., Ludvigsson, J., Pozzilli, P., Lachin, J. M., Kolb, H., & The Type 1 Diabetes Trial Net Research Group and the European C-Peptide Trial Study Group (2008) · Diabetes Care · doi:10.2337/dc07-2451 · Cited by 285
Törn, C., Mueller, P. W., Schlosser, M., Bonifacio, E., Bingley, P. J., & Laboratories, P. (2008) · Diabetologia · doi:10.1007/s00125-008-0967-2 · Cited by 284
Islet-associated macrophages in type 2 diabetes
Richardson, S. J., Willcox, A., Bone, A. J., Foulis, A. K., & Morgan, N. G. (2009) · Diabetologia · doi:10.1007/s00125-009-1410-z · Cited by 239
Antiislet autoantibodies usually develop sequentially rather than simultaneously
Yu, L. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.12.4264 · Cited by 214 · cited 6×
“Liping Yu and George Eisenbarth at the Barbara Davis Center (19).”
Influential
Research works printed but not linked: 1
- Ringquist, 2007, Transplantation genetics, 983
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus
Akash, M. S. H., Rehman, K., & Chen, S. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24402 · Cited by 407
“Interestingly, other than these determinants, recently autoimmune participants causing inflammation have been also considered playing their role in insulin resistance by affecting b-cells of pancreatic islets [Brooks-Worrell et al., 2011; Goldfine et al., 2011].”
BackgroundAdult-onset autoimmune diabetes: current knowledge and implications for management
Buzzetti, R., Zampetti, S., & Maddaloni, E. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.99 · Cited by 271
“Furthermore, a new autoantibody against the extracytoplasmatic (EC) IA-2EC(26-577) region can identify a novel antigenic determinant within the N terminus of the IA-2 protein76.”
BackgroundDiabetes at the crossroads: relevance of disease classification to pathophysiology and treatment
Leslie, R. D., Palmer, J., Schloot, N. C., & Lernmark, A. (2016) · Diabetologia · doi:10.1007/s00125-015-3789-z · Cited by 204
Self-citationDiabetes and beta cell function: from mechanisms to evaluation and clinical implications
Cernea, S., & Dobreanu, M. (2013) · Biochemia Medica · doi:10.11613/bm.2013.033 · Cited by 203
“Some phenotypic T2DM subjects also present markers of autoimmunity and these are correlated with beta cell function, suggesting a possible role of immune system in the pathogenesis of T2DM (4,40,41).”
BackgroundHeterogeneity and endotypes in type 1 diabetes mellitus
Redondo, M. J., & Morgan, N. G. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00853-0 · Cited by 167
Latent autoimmune diabetes of the adult: current knowledge and uncertainty
Laugesen, E., Østergaard, J. A., Leslie, R. D. G., & the Danish Diabetes Academy Workshop and Workshop Speakers (2015) · Diabetic Medicine · doi:10.1111/dme.12700 · Cited by 164
Butcher, M. J., Hallinger, D., Garcia, E., Machida, Y., Chakrabarti, S., Nadler, J., Galkina, E. V., & Imai, Y. (2014) · Diabetologia · doi:10.1007/s00125-013-3116-5 · Cited by 160
“Circulating T cells reactive to islets are detectable in type 2 diabetic patients [12].”
BackgroundIslet inflammation: a unifying target for diabetes treatment?
Imai, Y., Dobrian, A. D., Morris, M. A., & Nadler, J. L. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.01.007 · Cited by 119
“However, peripheral blood T cells from 42% of clinically defined T2D patients react against islet extracts, despite of the lack of islet antibodies in these patients, suggesting that adaptive immunity may be involved at a significant frequency in clinically defined T2D (Box 3) [63].”
BackgroundType 2 Diabetes: How Much of an Autoimmune Disease?
de Candia, P., Prattichizzo, F., Garavelli, S., Rosa, V. D., Galgani, M., Rella, F. D., Spagnuolo, M. I., Colamatteo, A., Fusco, C., Micillo, T., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00451 · Cited by 130
Hao, H., Liu, J., Shen, J., Zhao, Y., Liu, H., Hou, Q., Tong, C., Ti, D., Dong, L., Cheng, Y., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.117 · Cited by 119
“clinical showed that inflammation is now accepted as one factor in the pathology of T2D, and possibly the underlying cause of b-cell death [21–26].”
Autoimmune Aspects of Type 2 Diabetes Mellitus - A Mini-Review
Itariu, B. K., & Stulnig, T. M. (2014) · Gerontology · doi:10.1159/000356747 · Cited by 107
Latent Autoimmune Diabetes in Adults: Current Status and New Horizons
Pozzilli, P., & Pieralice, S. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.2.147 · Cited by 130
Pietropaolo, M., Towns, R., & Eisenbarth, G. S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012831 · Cited by 95
“Additionally, it has been previously reported that LADApatients possess T cells reactive to islet proteins as is also the case in “canonical” type 1 diabetes, in contrast to classic autoantibody-negative T2D patients (Brooks-Worrell et al. 2011).”
BackgroundZhao, Y. L., Jiang, Z., Zhao, T., Ye, M., Hu, C., Zhou, H., Yin, Z., Chen, Y., Zhang, Y., Wang, S., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-160 · Cited by 89
“Importantly, mounting evidence collected over the past decade indicates that the etiology of T2D includes an autoimmune component that initiates an inflammation affecting pancreatic islet β cells [8,28-32], which provides new insight into the mechanism and potential treatment of insulin resistance through immune modul…”
BackgroundSarikonda, G., Pettus, J., Phatak, S., Sachithanantham, S., Miller, J. F., Wesley, J. D., Cadag, E., Chae, J., Ganesan, L., Mallios, R., et al. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.003 · Cited by 83
Targeting inflammation in the treatment of type 2 diabetes
Donath, M. Y. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12172 · Cited by 83
“Their number increases with time and seems to correlate with a precipitation of the progression of the disease [22].”
BackgroundBrooks-Worrell, B., & Palmer, J. P. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04501.x · Cited by 82
Self-citationThe β Cell in Diabetes: Integrating Biomarkers With Functional Measures
Kahn, S. E., Chen, Y., Esser, N., Taylor, A. J., van Raalte, D. H., Zraika, S., & Verchere, C. B. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab021 · Cited by 80
“Studies from one group have raised the possibility that T cells autoreactive to β-cell proteins may also be present in people with type 2 diabetes (304).”
BackgroundAdult-onset autoimmune diabetes
Buzzetti, R., Maddaloni, E., Gaglia, J. L., Leslie, R. D., Wong, F. S., & Boehm, B. O. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00390-6 · Cited by 71
The potential role of glutamate in the current diabetes epidemic
Davalli, A. M., Perego, C., & Folli, F. B. (2012) · Acta Diabetologica · doi:10.1007/s00592-011-0364-z · Cited by 64
“Moreover, a considerable subgroup of adult and pediatric T2D subjects present evidence of humoral and cellular b-cell autoimmunity [14–18] that is more common than previously thought and that may contribute significantly to the progressive decline in b-cell function observed in T2D patients.”
BackgroundThe outliers become a stampede as immunometabolism reaches a tipping point
Nikolajczyk, B. S., Jagannathan‐Bogdan, M., & Denis, G. V. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01142.x · Cited by 58
“A dual characterization of clinically diagnosed ‘T2D’ patients based on the presence of circulating anti-islet antibodies and islet-reactive T cells indicated a significant percentage of T2D diagnoses (>20%) may instead be LADA (100, 101).”
BackgroundInfluentialPast, present and future of latent autoimmune diabetes in adults
Liu, B., Xiang, Y., Liu, Z., & Zhou, Z. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3205 · Cited by 50
Adult-onset autoimmune diabetes in 2020: An update
Maddaloni, E., Moretti, C., Mignogna, C., & Buzzetti, R. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.04.014 · Cited by 53
Biomarkers and immune-modulating therapies for Type 2 diabetes
Brooks‐Worrell, B., Narla, R. R., & Palmer, J. P. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.07.002 · Cited by 50
Self-citationMolecular and cellular bases of diabetes: Focus on type 2 diabetes mouse model-TallyHo
Tamarai, K., Bhatti, J. S., & Reddy, P. H. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.05.004 · Cited by 45
Impact of Islet Autoimmunity on the Progressive β-Cell Functional Decline in Type 2 Diabetes
Brooks-Worrell, B. M., Boyko, E. J., & Palmer, J. P. (2014) · Diabetes Care · doi:10.2337/dc14-0961 · Cited by 45
Self-citationIslet autoimmunity in phenotypic type 2 diabetes patients
Brooks‐Worrell, B., Narla, R., & Palmer, J. P. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12167 · Cited by 41
“How does the presence of islet-specific T cells correlate with β-cell function in T2D pathophysiology? Previous studies have demonstrated that islet-reactive T cells appeared to be associated with the progressive loss of β-cell function in T2D patients [25,30,32].”
BackgroundResultInfluentialSelf-citationZhao, Y. L., Jiang, Z., & Guo, C. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.09.003 · Cited by 44
Adaptive Immunity and Antigen‐Specific Activation in Obesity‐Associated Insulin Resistance
Chng, M. H. Y., Alonso, M. N., Barnes, S. E., Nguyen, K. D., & Engleman, E. G. (2015) · Mediators of Inflammation · doi:10.1155/2015/593075 · Cited by 39
“In addition, T cell autoimmunity to islet antigens has been identified in phenotypic T2D patients that lack autoantibodies to these antigens [128].”
BackgroundBrooks-Worrell, B. M., & Palmer, J. P. (2019) · Diabetes Care · doi:10.2337/dc19-0475 · Cited by 38
Self-citationDefining and Classifying New Subgroups of Diabetes
Balasubramanyam, A. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-050219-034524 · Cited by 41
Brooks‐Worrell, B., Iyer, D., Coraza, I., Hampe, C. S., Nalini, R., Özer, K., Narla, R. R., Palmer, J. P., & Balasubramanyam, A. (2013) · Diabetes Care · doi:10.2337/dc12-2328 · Cited by 34
“and phenotypic type 2 diabetic patients (5,6,10,11,13,14,19).”
BackgroundResultSelf-citationAcevedo-Calado, M., James, E. A., Morran, M. P., Pietropaolo, S. L., Ouyang, Q., Arribas-Layton, D., Songini, M., Liguori, M., Casu, A., Auchus, R. J., et al. (2017) · Diabetes Care · doi:10.2337/dc16-1527 · Cited by 35
“(42) reported isletreactive T cells in up to 50% of seronegative patients with type 2 diabetes.”
BackgroundHyaluronan: A Mediator of Islet Dysfunction and Destruction in Diabetes?
Hull, R. L., Bogdani, M., Nagy, N., Johnson, P. Y., & Wight, T. N. (2015) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415576542 · Cited by 36
“Mice with β-cell FAK deletion show impaired β-cell function (Cai et al. 2012).”
BackgroundWu, X., Ying, H., Yang, Q., Yang, Q., Liu, H., Ding, Y., Zhao, H., Chen, Z., Zheng, R., Lin, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53621-7 · Cited by 36
Pouresmaeil, V., Abudi, A. H. A., Mahimid, A. H., Yazdi, M. S., & Es‐haghi, A. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03191-w · Cited by 33
Zaharieva, E., Velikova, T. V., Tsakova, A. D., & Kamenov, Z. A. (2017) · Journal of Diabetes Research · doi:10.1155/2017/9016148 · Cited by 34
“Despite titer fluctuations and results with borderline values, transitional outreaching of reference range might suggest a predisposition to autoimmune response and autoreactive T cells have been described in autoantibody-negative patients [25].”
BackgroundThe Clinical And Metabolic Characteristics Of Young-Onset Ketosis-Prone Type 2 Diabetes In China
Zhang, M., Li, Y., Cui, W., Yang, P., Li, H., Sheng, C., Cheng, X., & Qu, S. (2015) · Endocrine Practice · doi:10.4158/ep15778.or · Cited by 29
Brooks-Worrell, B., Hampe, C. S., Hattery, E. G., Palomino, B., Zangeneh, S. Z., Utzschneider, K., Kahn, S. E., Larkin, M. E., Johnson, M. L., Mather, K. J., et al. (2022) · Diabetes · doi:10.2337/db21-0590 · Cited by 33
Self-citationShould There be Concern About Autoimmune Diabetes in Adults? Current Evidence and Controversies
Østergaard, J. A., Laugesen, E., & Leslie, R. D. G. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0780-0 · Cited by 25
Subauste, A. R., Gianani, R., Chang, A. M., Plunkett, C. D., Pietropaolo, S. L., Zhang, Y.-J., Barinas‐Mitchell, E., Kuller, L. H., Gałecki, A. T., Halter, J. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106537 · Cited by 23
“Additionally, it has also been shown that, as is the case with ‘‘canonical’’ T1DM patients, LADA patients also possess T-cells reactive to islet proteins [37].”
ResultTan, T., Xiang, Y., Deng, C., Cao, C., Ren, Z., Huang, G., & Zhou, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974864 · Cited by 23
“Similarly, a proportion of adult phenotypic type 2 diabetes (T2D) patients who are autoantibody negative demonstrated autoimmune T-cell responses (5, 6).”
BackgroundBrooks‐Worrell, B., & Palmer, J. P. (2012) · Clinical & Experimental Immunology · doi:10.1111/cei.12012 · Cited by 23
Self-citationChang, D. C., Piaggi, P., Hanson, R. L., Knowler, W. C., Bucci, J., Thio, G., Hohenadel, M. G., Bogardus, C., & Krakoff, J. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143551 · Cited by 21
“However not all such patients with an islet reactive T cell response had previously-described T1DM-associated autoantibodies [10].”
Background‘Sensing’ the link between type 1 and type 2 diabetes
Tsui, H., Paltser, G., Chan, Y., Dorfman, R., & Dosch, H. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1279 · Cited by 19
Koufakis, T., Dimitriadis, G., Metallidis, S., Zebekakis, P. E., & Kotsa, K. (2021) · Obesity Reviews · doi:10.1111/obr.13231 · Cited by 22
“Brooks-Worrell et al.(63) screened 36 adults with T2D phenotype for”
BackgroundLatent autoimmune diabetes in adults in China
Qiu, J., Xiao, Z., Zhang, Z., Luo, S., & Zhou, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.977413 · Cited by 21
Gao, X., Sun, W., Wang, Y., Zhang, Y., Li, R., Huang, J., & Yang, Y. (2019) · Endocrine Connections · doi:10.1530/ec-19-0379 · Cited by 18
T‐cell receptor repertoire variation may be associated with type 2 diabetes mellitus in humans
Frankl, J. A., Thearle, M. S., Desmarais, C., Bogardus, C., & Krakoff, J. A. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2720 · Cited by 19
“A subgroup of autoantibody negative but autoreactive T-cell positive individuals has also been identified [8] indicating that islet cell antibodies are not absolutely necessary for adaptive immune systemparticipation in development of diabetes.”
BackgroundEvaluation of submandibular and parotid salivary glands by ultrasonography in patients with diabetes
Öztürk, E. M. A., & Yalçın, E. D. (2024) · Journal of Oral Rehabilitation · doi:10.1111/joor.13685 · Cited by 15
Martinović, T., Ćirić, D., Pantic, I. V., Lalic, K. S., Rasulić, I., Despotović, S. Z., Lalić, I. M., Djuricic, D., Bumbaširević, V., & Kravic‐Stevovic, T. (2018) · Tissue and Cell · doi:10.1016/j.tice.2018.04.005 · Cited by 16
Katahira, M., Ogata, H., Ito, T., Tsutomu, M., Goto, M., Nakamura, S., & Takashima, H. (2018) · Journal of Diabetes Research · doi:10.1155/2018/1847430 · Cited by 17
“demonstrated that a significantly lower response for stimulated C-peptide was observed in T2D patients with a positive T-cell response compared with those with a negative T-cell response [23].”
BackgroundResultLiang, H., Cheng, Y., Tang, W., Cui, Q., Yuan, J., Huang, G., Yang, L., & Zhou, Z. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01391-w · Cited by 15
Family history of Type 1 diabetes affects insulin secretion in patients with ‘Type 2’ diabetes
Lundgren, V., Andersen, M. K., Isomaa, B., & Tuomilehto, J. (2012) · Diabetic Medicine · doi:10.1111/dme.12069 · Cited by 11
Satomura, A., Oikawa, Y., Haisa, A., Suzuki, S., Nakanishi, S., Katsuki, T., & Shimada, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab912 · Cited by 11
LADA: A Type of Diabetes in its Own Right?
Grill, V. (2019) · Current Diabetes Reviews · doi:10.2174/1573399814666180716150905 · Cited by 12
Buryk, M. A., Dosch, H. ‐., Libman, I. M., Arena, V. C., Huang, Y., Cheung, R. K., Trucco, M., Pietropaolo, M., & BECKER, D. J. (2014) · Diabetes Care · doi:10.2337/dc14-1861 · Cited by 8
“Similar diabetes-selective T-cell reactivities to islet cell proteins have been demonstrated in children (9) and adults with clinical type 2 diabetes regardless of autoantibody status (10) and have been associated with significantly low C-peptide levels in adults (10).”
BackgroundMethodThe Potential of VipAlbumin® to Chronic Inflammation in Type 2 Diabetes Mellitus Balb/C Mice Model
Dwijayanti, D. R., Djati, M. S., Ibrahim, M., & Rifa’i, M. (2015) · American Journal of Immunology · doi:10.3844/ajisp.2015.56.67 · Cited by 8
“Brooks-Worrell et al. (2011) mentions that in the peripheral blood of patients with type 2 DM, it was also found 42% increase in T cells that react against β cells.”
BackgroundSun, Q., Yang, P. C., Gu, Q., Gu, W.-S., Wang, W., Wang, J., & Mao, X. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108738 · Cited by 6
Diabetes mellitus – um «continuum» fisiopatológico
Guelho, D., Paiva, I., & Carvalheiro, M. C. (2013) · Endocrinology Insights · doi:10.1016/j.rpedm.2013.05.002 · Cited by 27
Inflammatory Pathways Linked to Beta Cell Demise in Diabetes
Imai, Y., Morris, M. A., Dobrian, A. D., Taylor, D., & Nadler, J. L. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_30-2 · Cited by 6
“Of 11 antibody positive subjects, only 4 were positive for GADA, an antibody commonly used to diagnose LADA (Brooks-Worrell et al. 2011).”
BackgroundRelationship between serum GAD-Ab and the genetic polymorphisms of GAD2 and type 2 diabetes mellitus
Li, Q., Qiao, Z. R., Liu, D. B., Zeng, J. T., Zhang, J., Bo, Y., Zu, H., Hu, Q., Wu, X., & Dong, S. (2015) · Genetics and Molecular Research · doi:10.4238/2015.april.10.10 · Cited by 4
Autoimmune diseases and metabolic disorders: Molecular connections and potential therapeutic targets
Uddin, M. J., Tran, D. K., Hannan, M. A., Hasan-Al-Faruque, Rahman, M. A., Moni, A., Lam, N. T., Ngọc, V. T. N., & Chu, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85415-3.00018-0 · Cited by 2
Patti, L. (2023) · The Journal of AMD · doi:10.36171/jamd23.26.2.7 · Cited by 2
Immune Disorders and Sex Differences in Spontaneously Diabetic Torii Rats, Type 2 Diabetic Model
Kobayashi, K., Sasase, T., Maekawa, T., Shinozaki, Y., Sano, R., Yamada, T., & Ohta, T. (2022) · Physiological Research · doi:10.33549/physiolres.934825 · Cited by 2
L’internista ospedaliero nella gestione del paziente diabetico complesso
Magnani, G. E. L., Beltramello, G., Brancato, D., Fontanella, A., & Nardi, R. (2018) · Italian Journal of Medicine · doi:10.4081/itjm.q.2018.2 · Cited by 2
Statistical considerations when analyzing biomarker data
Beam, C. A. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.05.019 · Cited by 1
Cord Blood Stem Cells for Clinical Use
Zhao, Y. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407785-0.00012-8 · Cited by 1
TYPE 2 DIABETES MELLITUS – AN AUTOIMMUNE DISEASE?
Asfandiyarova, N. S. (2020) · Russian Journal of Immunology · doi:10.46235/1028-7221-001-tdm · Cited by 1
“Участие аутоиммунных реакций в генезе СД 2 типа подтверждается и обнаружением сенсибилизированных Т-лимфоцитов к антигенам островковых клеток [12, 13].”
T-Cell Autoreactivity in Type 2 Diabetes: Benign or Pathogenic, Smoke or Fire?
Jones, A. G., & Eichmann, M. (2022) · Diabetes · doi:10.2337/dbi22-0007 · Cited by 1
Immune and metabolic changes leading to diabetes
Hawa, M. I. (2012) · Cited by 2
Current Status of Stem Cell Therapy in China
Zhu, H., & Huang, X. (2013) · International Journal of Hematologic Oncology · doi:10.2217/ijh.13.33
The Predictive Value of Biopsy of the Pancreas and Its Therapeutic Impact in Autoimmune Diabetes
Nassar, W., & Mostafa, M. A. (2014) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2014.44041
“Moreover, islet-reactive T cells responding to multiple islet proteins have been found in both T1DM patients and phenotypic T2DM patients with or without islet autoantibodies [1]-[3], emphasizing the need to implicate early immune-based therapeutic interventions in treatment of pre-hyperglycemic stage of diabetic pati…”
BackgroundCellular Immunological Mechanisms Contributing to Diabetes Pathogenesis
Radenkovic, M. (2016) · Lund University Publications (Lund University)
Biopsy of the pancreas: the predictive value and therapeutic impact on autoimmune diabetes
Nassar, W., & Mostafa, M. A. (2015) · The Egyptian Journal of Internal Medicine · doi:10.4103/1110-7782.159449
Maskierter Typ-1-Diabetes oder doch Typ-2-Diabetes?
Schloot, N. C. (2018) · Info Diabetologie · doi:10.1007/s15034-018-1260-1
Latent Autoimmune Diabetes in Adults: The Current Understanding and Challenge
Tseng, K.-B. (2021) · 內科學誌 · doi:10.6314/jimt.202104_32(2).02
Inflammatory Pathways Linked to β Cell Demise in Diabetes
Imai, Y., Morris, M. A., Dobrian, A. D., Taylor, D., & Nadler, J. L. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_30
Adult-onset autoimmune diabetes
(2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00397-z
Research Progress on Clinical Classification of Diabetes Based on Precision Medicine
张, 玉. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.141019
Alexander, L., Cheng-ting, T., Lernmark, Å., & JENDLE, J. H. (2024) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2024.100367 · Cited by 1
“If islet autoimmunity precedes the onset of T2D, as indicated by the presence of autoreactive T cells in both islet autoantibody positive and negative T2D individuals [33 – 35], this may indicate an autoimmune triggering mechanism.”
BackgroundGoga, T. M., & Zeqiraj, A. (2025) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.21.8.2025.1663
Metadata
- Authors
- Brooks-Worrell, B. M., Reichow, J. L., Goel, A., Ismail, H., & Palmer, J. P.
- Affiliations
- Department of Medicine, University of Washington, Seattle, Washington;
- Seattle Institute for Biomedical and Clinical Research (US)
- Bronx-Lebanon Hospital Center (US)
- Cairo University (EG)
- United States Department of Veterans Affairs (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-09-20
- Volume
- 34
- Issue
- 1
- Pages
- 168-173
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3004952
- OpenAlex
- W2033958293
- Cited by
- 83
- References
- 28
- Citations by year
- 2025: 1 · 2024: 5 · 2023: 2 · 2022: 9 · 2021: 5 · 2020: 3 · 2019: 7 · 2018: 5 · 2017: 3 · 2016: 2 · 2015: 11 · 2014: 10 · 2013: 9 · 2012: 8
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- GlaxoSmithKline
- University of Florida
- University of Washington
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK053004, P30DK017047)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- type 2 diabetes, islet autoimmunity, islet autoantibodies, beta-cell function, C-peptide response, GAD65 antibodies, insulin autoantibodies, diabetes subgroups
- MeSH terms
- Adult, Aged, Autoantibodies, C-Peptide, Diabetes Mellitus, Type 2, Haplotypes, Humans, Insulin Resistance, Middle Aged, T-Lymphocytes, Immunoblotting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.